Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen

Identifieur interne : 000521 ( Main/Exploration ); précédent : 000520; suivant : 000522

Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen

Auteurs : RBID : ISTEX:262_1988_Article_BF00199935.pdf

Abstract

The monoclonal antibody, 3A33, directed against Mac-1 antigen which is expressed essentially on macrophages and polymorphonuclear cells, was injected i.v. into mice, as part of an attempt to visualize inflammatory lesions and tumours by external scintigraphy. The monoclonal antibody, a rat IgG2a, was conjugated with a bifunctional chelating agent, diethylenetriaminepentaacetic acid at a 1:1 molecular ratio and complexed with 111-indium, a procedure which apparently did not alter its binding to peritoneal macrophages and provided relatively stable cell labelling. An unrelated rat IgG2a of unknown specificity radiolabelled in the same manner as 3A33 served as a control. The uptake of i.v. injected 3A33 by peritoneal macrophages was up to 50 times that of unrelated IgG2a. After i.v. inoculation, the antibody accumulated in the liver, spleen, lung, in foot-pad inflammatory reactions induced by injection of Freund's adjuvant and in experimentally grafted tumours. The 3A33: non-specific IgG2a uptake ratio in inflammatory lesions and tumours, however, was much lower than for peritoneal macrophages and was generally close to 2. This was sufficient to obtain scintigraphic images of inflammations and tumours. The images obtained after injection of 3A33 were clearly of better quality than those given by the non-specific immunoglobulin. They could be improved by subtraction of the vascular images obtained after injection of 99m-technetium serum albumin. The labelling of Mac-1-positive blood mononuclear cells by in vitro incubation with radioactive 3A33 was not intense enough to allow scintigraphic imaging after in vivo re-infusion but seemed more selective than the injection of whole antibody in detecting inflammatory reactions. These results seem interesting in view of the potential human application to the detection inflammatory lesions and the appreciation of tumour inflammatory components. Possible improvements in the technique are discussed.

DOI: 10.1007/BF00199935

Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title>Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen</title>
<author>
<name>Brigitte Collet</name>
<affiliation wicri:level="3">
<mods:affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Bretagne</region>
<settlement type="city">Rennes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name>Pascal Pellen</name>
<affiliation wicri:level="3">
<mods:affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Bretagne</region>
<settlement type="city">Rennes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name>Anne Martin</name>
<affiliation wicri:level="3">
<mods:affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Bretagne</region>
<settlement type="city">Rennes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name>Annick Moisan</name>
<affiliation wicri:level="3">
<mods:affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Bretagne</region>
<settlement type="city">Rennes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name>Dominique Bourel</name>
<affiliation wicri:level="3">
<mods:affiliation>Centre Régional de Transfusion Sanguine de Rennes, F-35033, Rennes, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Régional de Transfusion Sanguine de Rennes, F-35033, Rennes</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Bretagne</region>
<settlement type="city">Rennes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name>Louis Toujas</name>
<affiliation wicri:level="3">
<mods:affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Bretagne</region>
<settlement type="city">Rennes</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="RBID">ISTEX:262_1988_Article_BF00199935.pdf</idno>
<date when="1988">1988</date>
<idno type="doi">10.1007/BF00199935</idno>
<idno type="wicri:Area/Main/Corpus">000A02</idno>
<idno type="wicri:Area/Main/Curation">000A02</idno>
<idno type="wicri:Area/Main/Exploration">000521</idno>
</publicationStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="eng">The monoclonal antibody, 3A33, directed against Mac-1 antigen which is expressed essentially on macrophages and polymorphonuclear cells, was injected i.v. into mice, as part of an attempt to visualize inflammatory lesions and tumours by external scintigraphy. The monoclonal antibody, a rat IgG2a, was conjugated with a bifunctional chelating agent, diethylenetriaminepentaacetic acid at a 1:1 molecular ratio and complexed with 111-indium, a procedure which apparently did not alter its binding to peritoneal macrophages and provided relatively stable cell labelling. An unrelated rat IgG2a of unknown specificity radiolabelled in the same manner as 3A33 served as a control. The uptake of i.v. injected 3A33 by peritoneal macrophages was up to 50 times that of unrelated IgG2a. After i.v. inoculation, the antibody accumulated in the liver, spleen, lung, in foot-pad inflammatory reactions induced by injection of Freund's adjuvant and in experimentally grafted tumours. The 3A33: non-specific IgG2a uptake ratio in inflammatory lesions and tumours, however, was much lower than for peritoneal macrophages and was generally close to 2. This was sufficient to obtain scintigraphic images of inflammations and tumours. The images obtained after injection of 3A33 were clearly of better quality than those given by the non-specific immunoglobulin. They could be improved by subtraction of the vascular images obtained after injection of 99m-technetium serum albumin. The labelling of Mac-1-positive blood mononuclear cells by in vitro incubation with radioactive 3A33 was not intense enough to allow scintigraphic imaging after in vivo re-infusion but seemed more selective than the injection of whole antibody in detecting inflammatory reactions. These results seem interesting in view of the potential human application to the detection inflammatory lesions and the appreciation of tumour inflammatory components. Possible improvements in the technique are discussed.</div>
</front>
</TEI>
<mods xsi:schemaLocation="http://www.loc.gov/mods/v3 file:///applis/istex/home/loadistex/home/etc/xsd/mods.xsd" version="3.4" istexId="b032232eaa529f8cdb30ee59a19b04f22d3aca1a">
<titleInfo lang="eng">
<title>Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen</title>
</titleInfo>
<name type="personal">
<namePart type="given">Brigitte</namePart>
<namePart type="family">Collet</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</affiliation>
</name>
<name type="personal">
<namePart type="given">Pascal</namePart>
<namePart type="family">Pellen</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</affiliation>
</name>
<name type="personal">
<namePart type="given">Anne</namePart>
<namePart type="family">Martin</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</affiliation>
</name>
<name type="personal">
<namePart type="given">Annick</namePart>
<namePart type="family">Moisan</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</affiliation>
</name>
<name type="personal">
<namePart type="given">Dominique</namePart>
<namePart type="family">Bourel</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>Centre Régional de Transfusion Sanguine de Rennes, F-35033, Rennes, France</affiliation>
</name>
<name type="personal">
<namePart type="given">Louis</namePart>
<namePart type="family">Toujas</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
<affiliation>Centre Régional de Lutte contre le Cancer Pontchaillou, F-35033, Rennes-Cedex, France</affiliation>
</name>
<typeOfResource>text</typeOfResource>
<genre>Original Articles</genre>
<genre>Original Paper</genre>
<originInfo>
<publisher>Springer-Verlag, Berlin/Heidelberg</publisher>
<dateCreated encoding="w3cdtf">1987-12-08</dateCreated>
<dateCaptured encoding="w3cdtf">1988-01-11</dateCaptured>
<dateValid encoding="w3cdtf">2004-07-14</dateValid>
<copyrightDate encoding="w3cdtf">1988</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="eng">The monoclonal antibody, 3A33, directed against Mac-1 antigen which is expressed essentially on macrophages and polymorphonuclear cells, was injected i.v. into mice, as part of an attempt to visualize inflammatory lesions and tumours by external scintigraphy. The monoclonal antibody, a rat IgG2a, was conjugated with a bifunctional chelating agent, diethylenetriaminepentaacetic acid at a 1:1 molecular ratio and complexed with 111-indium, a procedure which apparently did not alter its binding to peritoneal macrophages and provided relatively stable cell labelling. An unrelated rat IgG2a of unknown specificity radiolabelled in the same manner as 3A33 served as a control. The uptake of i.v. injected 3A33 by peritoneal macrophages was up to 50 times that of unrelated IgG2a. After i.v. inoculation, the antibody accumulated in the liver, spleen, lung, in foot-pad inflammatory reactions induced by injection of Freund's adjuvant and in experimentally grafted tumours. The 3A33: non-specific IgG2a uptake ratio in inflammatory lesions and tumours, however, was much lower than for peritoneal macrophages and was generally close to 2. This was sufficient to obtain scintigraphic images of inflammations and tumours. The images obtained after injection of 3A33 were clearly of better quality than those given by the non-specific immunoglobulin. They could be improved by subtraction of the vascular images obtained after injection of 99m-technetium serum albumin. The labelling of Mac-1-positive blood mononuclear cells by in vitro incubation with radioactive 3A33 was not intense enough to allow scintigraphic imaging after in vivo re-infusion but seemed more selective than the injection of whole antibody in detecting inflammatory reactions. These results seem interesting in view of the potential human application to the detection inflammatory lesions and the appreciation of tumour inflammatory components. Possible improvements in the technique are discussed.</abstract>
<relatedItem type="series">
<titleInfo type="abbreviated">
<title>Cancer Immunol Immunother</title>
</titleInfo>
<titleInfo>
<title>Cancer Immunology, Immunotherapy</title>
<partNumber>Year: 1988</partNumber>
<partNumber>Volume: 26</partNumber>
<partNumber>Number: 3</partNumber>
</titleInfo>
<genre>Archive Journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">1988-06-01</dateIssued>
<copyrightDate encoding="w3cdtf">1988</copyrightDate>
</originInfo>
<subject usage="primary">
<topic>Biomedicine</topic>
<topic>Cancer Research</topic>
<topic>Immunology</topic>
<topic>Oncology</topic>
</subject>
<identifier type="issn">0340-7004</identifier>
<identifier type="issn">Electronic: 1432-0851</identifier>
<identifier type="matrixNumber">262</identifier>
<identifier type="local">IssueArticleCount: 14</identifier>
<recordInfo>
<recordOrigin>Springer-Verlag, 1988</recordOrigin>
</recordInfo>
</relatedItem>
<identifier type="doi">10.1007/BF00199935</identifier>
<identifier type="matrixNumber">Art7</identifier>
<identifier type="local">BF00199935</identifier>
<accessCondition type="use and reproduction">MetadataGrant: OpenAccess</accessCondition>
<accessCondition type="use and reproduction">AbstractGrant: OpenAccess</accessCondition>
<accessCondition type="restriction on access">BodyPDFGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">BodyHTMLGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">BibliographyGrant: Restricted</accessCondition>
<accessCondition type="restriction on access">ESMGrant: Restricted</accessCondition>
<part>
<extent unit="pages">
<start>237</start>
<end>242</end>
</extent>
</part>
<recordInfo>
<recordOrigin>Springer-Verlag, 1988</recordOrigin>
<recordIdentifier>262_1988_Article_BF00199935.pdf</recordIdentifier>
</recordInfo>
</mods>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000521 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000521 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:262_1988_Article_BF00199935.pdf
   |texte=   Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen
}}

Wicri

This area was generated with Dilib version V0.5.81.
Data generation: Mon Aug 25 10:35:12 2014. Site generation: Thu Mar 7 10:08:40 2024